Nu Skin stockholders approve amended 2024 incentive plan with 790k additional shares and extension to 2035

NU SKIN ENTERPRISES, INC.

Stockholders approved Amended and Restated 2024 Omnibus Incentive Plan, increasing share authorization by 790,000 shares (30,535,949 for, 1,899,631 against).
Plan termination date extended to May 29, 2035; clarifies performance cash awards not subject to minimum vesting.
All nine director nominees elected; advisory vote on executive compensation passed with ~93% support (30,210,716 for, 825,311 against).
Ratification of PricewaterhouseCoopers as independent auditor for 2025 passed with 38,374,875 for versus 492,904 against.

item 5.02item 5.07item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.